HHS moving forward on rebate reforms

Two days after the public comment period ended for its drug pricing blueprint, HHS has signaled that it is moving forward with initiatives to regulate drug rebating practices.

The HHS Office of the Inspector General (OIG) submitted a proposed rule on July 18 to the White House Office of Management and Budget titled “Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.”...